Mortality and cancer after 12 versus 30 months dual antiplatelet therapy. The Korean Outcomes Registry Evaluating Antithrombotics (KOREA) - Serebruany, V L; Kim, M H; Cabrera-Fuentes, H A (Thromb Haemost, 2017)
, et al.